Norpace (G.D. Searle LLC Division of Pfizer Inc)


Welcome to the PulseAid listing for the Norpace drug offered from G.D. Searle LLC Division of Pfizer Inc. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: G.D. Searle LLC Division of Pfizer Inc
NON-PROPRIETARY NAME: disopyramide phosphate
SUBSTANCE NAME: DISOPYRAMIDE PHOSPHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1977-09-01
END MARKETING DATE: 0000-00-00


Norpace HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNorpace from G.D. Searle LLC Division of Pfizer Inc
LABELER NAME: G.D. Searle LLC Division of Pfizer Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 1977-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0025-2752_234e0244-3072-4717-9de9-026d6e1f0642
PRODUCT NDC: 0025-2752
APPLICATION NUMBER: NDA017447

Other DISOPYRAMIDE PHOSPHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Disopyramide Phosphate
AvKARE, Inc.Disopyramide Phosphate
Carilion Materials ManagementNorpace
G.D. Searle LLC Division of Pfizer IncNorpace CR
Mayne Pharma Inc.Disopyramide Phosphate
Teva Pharmaceuticals USA IncDisopyramide Phosphate